The North America opioids drugs market is estimated to grow at a CAGR of 2.25% over the forecast period of 2019-2028. The high rate of approval and launch of new abuse-deterrent formulation (ADF) of the opioid drug, and increasing price of both branded and generic medicine, are some of the primary factors augmenting market growth in the region. The North America opioids drugs market is further surveyed by segmenting the region into the United States and Canada. The United States spends about 18% of its GDP on healthcare. Opioids are used as a pain reliever.
NORTH AMERICA OPIOIDS DRUGS MARKET FORECAST 2019-2028
North America Opioids Drug Market by Products (Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol and Other Products), by Application (Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, Deaddiction) and by Geography.
The North America opioids drugs market is estimated to grow at a CAGR of 2.25% over the forecast period of 2019-2028. The high rate of approval and launch of new abuse-deterrent formulation (ADF) of the opioid drug, and increasing price of both branded and generic medicine, are some of the primary factors augmenting market growth in the region.
To know more about this report, request a free sample copy
The North America opioids drugs market is further surveyed by segmenting the region into the United States and Canada. The United States spends about 18% of its GDP on healthcare. Opioids are used as a pain reliever. However, there is a growing tendency of its long term usage and abuse, resulting in addiction, physical dependence, and withdrawal symptoms. Opioids became an epidemic, where 11.5 million people misused prescription opioids, and about 20 thousand died due to synthetic opioids overdose. In 2016, former US president, Obama, signed legislation which granted state fund of more than USD 1billion for opioids treatment and prevention programs, and also for manufacturing naloxone to counteract opioid overdoses. The current US President, Trump, declared the epidemic a public health emergency, and signed a law to provide addiction treatment and increase research and development of alternative pain medications in 2017. In 2018, the FDA launched a roadmap, which aims at reducing the abuse and misuse of opioid drugs, though there are companies that have taken legal action to convince doctors for sales of opioids to stimulate the market. However, the US was already struggling with an epidemic of opioid overdose, and the outbreak of coronavirus has made getting treatment an ordeal.
Johnson & Johnson, founded in 1886 and headquartered in New Jersey, operates in three business segments, consumer, pharmaceutical, and medical devices. In June 2018, Johnson & Johnson Innovation and Boston University made an announcement of a five-year alliance to fundamentally change the way lung cancer is detected and treated.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- MARKET DEFINITION
- KEY DRIVERS
- INCREASING ROAD ACCIDENTS AND SURGICAL PROCEDURES
- ESCALATING PALLIATIVE CARE FOR PATIENTS SUFFERING INTENSELY
- USAGE OF ABUSE DETERRENT FORMULATIONS TO RESTRICT THE OPIOID ABUSE
- GROWING OCCURRENCE OF CHRONIC PAIN
- KEY RESTRAINTS
- MISUSE OF OPIOIDS
- STRINGENT REGULATORY FRAMEWORK
- OPIOID CRISIS ACROSS THE GLOBE
- INCREASING NUMBER OF LAWSUITS CASES AGAINST OPIOIDS MANUFACTURERS
- RISING OCCURRENCE OF DEATHS RELATED TO OPIOID OVERDOSE
- KEY ANALYTICS
- KEY INVESTMENT INSIGHTS
- PORTER’S FIVE FORCE ANALYSIS
- BUYER POWER
- SUPPLIER POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- REGULATORY FRAMEWORK
- TECHNOLOGICAL ADVANCEMENT
- MARKET BY PRODUCT
- BUPRENORPHINE
- FENTANYL
- HYDROCODONE
- MORPHINE
- OXYCODONE
- TRAMADOL
- OTHER PRODUCTS
- MARKET BY APPLICATION
- PAIN RELIEF
- CANCER PAIN
- POSTOPERATIVE PAIN MANAGEMENT
- LOW BACK PAIN
- ORTHOPEDIC
- FIBROMYALGIA
- NEUROPATHIC
- ANESTHESIA
- COUGH SUPPRESSION
- DIARRHEA SUPPRESSION
- DEADDICTION
- PAIN RELIEF
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- NORTH AMERICA
- COMPANY PROFILES
- ACURA PHARMACEUTICALS INC
- ALLERGAN PLC
- BIODELIVERY SCIENCES INTERNATIONAL INC
- CIPHER PHARMACEUTICALS INC
- COLLEGIUM PHARMACEUTICAL INC
- DAIICHI SANKYO INC
- EGALET CORP
- HIKMA PHARMACEUTICALS PLC
- INDIVIOR INC
- JANSSEN PHARMACEUTICALS INC
- JOHNSON & JOHNSON
- LANNETT CO. INC
- LUPIN LTD
- MYLAN NV
- PFIZER INC
- PURDUE PHARMA LP
- SANOFI-AVENTIS S.A
- SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
- TEVA PHARMACEUTICAL INDUSTRIES LTD
TABLE LIST
TABLE 1: MARKET SNAPSHOT – OPIOIDS DRUGS
TABLE 2: FDA APPROVED OPIOIDS WITH ADF LABELLING
TABLE 3: NUMBER OF LAWSUITS CASES SETTLED BY OPIOIDS MANUFACTURING COMPANIES AND PHARMACIES, 2015–2027
TABLE 4: LIST OF ER/LA OPIOID BRANDED DRUGS, 2017
TABLE 5: LIST OF ER/LA OPIOID GENERIC DRUGS, 2017
TABLE 6: CDC GUIDELINES ON PRESCRIBING OPIOIDS
TABLE 7: PIPELINE ANALYSIS OF OPIOID DRUGS
TABLE 8: NORTH AMERICA OPIOIDS DRUGS MARKET, BY PRODUCT, HISTORICAL YEARS 2016-2019 (IN $ MILLION)
TABLE 9: NORTH AMERICA OPIOIDS DRUGS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA OPIOIDS DRUGS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: NORTH AMERICA OPIOIDS DRUGS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA PAIN RELIEF MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION):
TABLE 13: NORTH AMERICA PAIN RELIEF MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: NORTH AMERICA OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
FIGURE LIST
FIGURE 1: KEY INVESTMENT INSIGHTS
FIGURE 2: PORTER’S FIVE FORCE ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: NORTH AMERICA OPIOIDS DRUGS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019
FIGURE 6: NORTH AMERICA OPIOIDS DRUGS MARKET, BY BUPRENORPHINE, 2019-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA OPIOIDS DRUGS MARKET, BY FENTANYL, 2019-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA OPIOIDS DRUGS MARKET, BY HYDROCODONE, 2019-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA OPIOIDS DRUGS MARKET, BY MORPHINE, 2019-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA OPIOIDS DRUGS MARKET, BY OXYCODONE, 2019-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA OPIOIDS DRUGS MARKET, BY TRAMADOL, 2019-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA OPIOIDS DRUGS MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA OPIOIDS DRUGS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019
FIGURE 14: NORTH AMERICA OPIOIDS DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA PAIN RELIEF MARKET, BY CANCER PAIN, 2019-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA PAIN RELIEF MARKET, BY POSTOPERATIVE PAIN MANAGEMENT, 2019-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA PAIN RELIEF MARKET, BY LOW BACK PAIN, 2019-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA PAIN RELIEF MARKET, BY ORTHOPEDIC, 2019-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA PAIN RELIEF MARKET, BY FIBROMYALGIA, 2019-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA PAIN RELIEF MARKET, BY NEUROPATHIC, 2019-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA OPIOIDS DRUGS MARKET, BY ANESTHESIA, 2019-2028 (IN $ MILLION)
FIGURE 22: NORTH AMERICA OPIOIDS DRUGS MARKET, BY COUGH SUPPRESSION, 2019-2028 (IN $ MILLION)
FIGURE 23: NORTH AMERICA OPIOIDS DRUGS MARKET, BY DIARRHEA SUPPRESSION, 2019-2028 (IN $ MILLION)
FIGURE 24: NORTH AMERICA OPIOIDS DRUGS MARKET, BY DEADDICTION, 2019-2028 (IN $ MILLION)
FIGURE 25: NORTH AMERICA OPIOIDS DRUGS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
FIGURE 26: THE UNITED STATES OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
FIGURE 27: CANADA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET BY PRODUCT
- BUPRENORPHINE
- FENTANYL
- HYDROCODONE
- MORPHINE
- OXYCODONE
- TRAMADOL
- OTHER PRODUCTS
- MARKET BY APPLICATION
- PAIN RELIEF
- CANCER PAIN
- POSTOPERATIVE PAIN MANAGEMENT
- LOW BACK PAIN
- ORTHOPEDIC
- FIBROMYALGIA
- NEUROPATHIC
- ANESTHESIA
- COUGH SUPPRESSION
- DIARRHEA SUPPRESSION
- DEADDICTION
- PAIN RELIEF
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.